Correlation Between Tarsus Pharmaceuticals and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Entrada Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Entrada Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Entrada Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Tarsus and Entrada is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Entrada Therapeutics
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.88 times more return on investment than Entrada Therapeutics. However, Tarsus Pharmaceuticals is 1.13 times less risky than Entrada Therapeutics. It trades about -0.15 of its potential returns per unit of risk. Entrada Therapeutics is currently generating about -0.39 per unit of risk. If you would invest 5,200 in Tarsus Pharmaceuticals on October 20, 2024 and sell it today you would lose (548.00) from holding Tarsus Pharmaceuticals or give up 10.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Entrada Therapeutics
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Entrada Therapeutics |
Tarsus Pharmaceuticals and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Entrada Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Entrada Therapeutics vs. Molecular Partners AG | Entrada Therapeutics vs. Pmv Pharmaceuticals | Entrada Therapeutics vs. Monte Rosa Therapeutics | Entrada Therapeutics vs. Vigil Neuroscience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |